(-0.88%) 4 967.23 points
(0.56%) 37 986 points
(-2.05%) 15 282 points
(0.62%) $83.24
(0.17%) $1.760
(0.36%) $2 406.70
(1.29%) $28.75
(-1.17%) $943.30
(-0.14%) $0.938
(-0.28%) $11.01
(0.55%) $0.808
(-0.96%) $93.00
Live Chart Being Loaded With Signals
Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men...
Stats | |
---|---|
Today's Volume | 5 043.00 |
Average Volume | 10 617.00 |
Market Cap | 62.31M |
EPS | €0 ( 2023-09-28 ) |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | -2.89 |
ATR14 | €0.0220 (1.17%) |
Affluent Medical SA Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Affluent Medical SA Financials
Annual | 2022 |
Revenue: | €1.34M |
Gross Profit: | €-1.10M (-82.45 %) |
EPS: | €-0.810 |
Q2 | 2023 |
Revenue: | €295 000 |
Gross Profit: | €-911 000 (-308.81 %) |
EPS: | €-0.290 |
Q1 | 2023 |
Revenue: | €295 000 |
Gross Profit: | €-223 499 (-75.76 %) |
EPS: | €0 |
Q4 | 2022 |
Revenue: | €317 000 |
Gross Profit: | €-902 000 (-284.54 %) |
EPS: | €-0.360 |
Financial Reports:
No articles found.
Affluent Medical SA
Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators